FDA Eyes Third Covid Shot for Immunocompromised Patients

The video discusses the evolving strategies for COVID-19 vaccinations, particularly focusing on the need for booster shots to maintain immunity. It highlights the differences in vaccination approaches between countries like Germany and Israel. The discussion also covers the financial implications for vaccine manufacturers like Moderna and Biontech, noting the market volatility and uncertainty surrounding long-term vaccine strategies.

What role does the German government play in the vaccination strategy for individuals with prior infections?

What uncertainties exist regarding the long-term need for booster shots?